rs28933673

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 1P and 3B. PP5BP4BS1_SupportingBS2_Supporting

The NM_000132.4(F8):​c.3169G>A​(p.Glu1057Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000397 in 1,207,994 control chromosomes in the GnomAD database, including 8 homozygotes. There are 166 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.00041 ( 8 hom. 160 hem. )

Consequence

F8
NM_000132.4 missense

Scores

3
6
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:3

Conservation

PhyloP100: 0.733
Variant links:
Genes affected
F8 (HGNC:3546): (coagulation factor VIII) This gene encodes coagulation factor VIII, which participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 and phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma and associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PP5
Variant X-154930621-C-T is Pathogenic according to our data. Variant chrX-154930621-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 10251.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=3, Pathogenic=1, Likely_pathogenic=2}. Variant chrX-154930621-C-T is described in Lovd as [Likely_pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.16821963). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000412 (452/1095913) while in subpopulation EAS AF= 0.0138 (416/30187). AF 95% confidence interval is 0.0127. There are 8 homozygotes in gnomad4_exome. There are 160 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd4 at 6 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
F8NM_000132.4 linkuse as main transcriptc.3169G>A p.Glu1057Lys missense_variant 14/26 ENST00000360256.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
F8ENST00000360256.9 linkuse as main transcriptc.3169G>A p.Glu1057Lys missense_variant 14/261 NM_000132.4 P1P00451-1
F8ENST00000647125.1 linkuse as main transcriptc.*2835G>A 3_prime_UTR_variant, NMD_transcript_variant 14/14

Frequencies

GnomAD3 genomes
AF:
0.000241
AC:
27
AN:
112031
Hom.:
0
Cov.:
23
AF XY:
0.000175
AC XY:
6
AN XY:
34231
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00667
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000591
AC:
108
AN:
182664
Hom.:
1
AF XY:
0.000534
AC XY:
36
AN XY:
67362
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00707
Gnomad SAS exome
AF:
0.000158
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000614
Gnomad OTH exome
AF:
0.000445
GnomAD4 exome
AF:
0.000412
AC:
452
AN:
1095913
Hom.:
8
Cov.:
32
AF XY:
0.000443
AC XY:
160
AN XY:
361351
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0138
Gnomad4 SAS exome
AF:
0.000148
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000131
Gnomad4 OTH exome
AF:
0.000326
GnomAD4 genome
AF:
0.000250
AC:
28
AN:
112081
Hom.:
0
Cov.:
23
AF XY:
0.000175
AC XY:
6
AN XY:
34291
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00669
Gnomad4 SAS
AF:
0.000370
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000565
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000334
Hom.:
0
Bravo
AF:
0.000230
ExAC
AF:
0.000634
AC:
77
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary factor VIII deficiency disease Pathogenic:3Uncertain:2
Likely pathogenic, criteria provided, single submitterclinical testingUCLA Clinical Genomics Center, UCLAApr 16, 2013- -
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 01, 1993- -
Likely pathogenic, criteria provided, single submitterreference populationSoonchunhyang University Bucheon Hospital, Soonchunhyang University Medical CenterMar 18, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 03, 2022The p.Glu1057Lys (NM_000132.3 c.3169G>A) variant in F8 has been reported hemizygously in three males with Hemophilia A and low factor VIII levels, though one of these individuals carried a second pathogenic variant (Higuchi 1991, Chan 1996, Huang 2009). This variant has also been reported in ClinVar (Variation ID#10251). This variant has been identified in 0.7% (95/13902) of East Asian chromosomes, including 1 homozygote and 29 hemizygotes, by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs28933673). In vitro functional studies provide some evidence that the p.Glu1057Lys variant may impact protein function (Pahl 2014); however, these types of assays may not accurately represent biological function. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Glu1057Lys variant is uncertain. -
Uncertain significance, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteFeb 02, 2022Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3B. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with haemophilia A (MIM#306700). (I) 0109 - This gene is associated with X-linked recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from glutamic acid to lysine. (I) 0253 - This variant is hemizygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (71 heterozygotes, 1 homozygote, 36 hemizygotes). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated B domain (PMID: 24108539). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. It has been reported in at least three individuals with haemophilia A (PMIDs: 1924291, 19719548, 30913330). It has also been reported as polymorphism in a haemophilia A cohort, and as hemizygous in an individual with haemophilia B (PMIDs: 18479430, 29296726). It has been reported as both likely pathogenic and uncertain significance in ClinVar. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1010 - Functional evidence for this variant is inconclusive. Authors of a functional study using transfected HEK cells described that the variant protein had mildly decreased factor VIII activity and significantly reduced thermostability (PMID: 24108539), however their raw data was incomplete and not convincing. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Thrombophilia, X-linked, due to factor 8 defect Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingMendelicsMay 04, 2022- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 03, 2023Variant summary: F8 c.3169G>A (p.Glu1057Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00059 in 182664 control chromosomes, predominantly at a frequency of 0.0071 within the East Asian subpopulation in the gnomAD database, including 1 homozygote and 36 hemizygotes across the subpopulations. This frequency is not significantly higher than estimated for a pathogenic variant in F8 causing Factor VIII Deficiency (Hemophilia A) (0.00059 vs 0.0098), allowing no conclusion about variant significance. c.3169G>A has been reported in the literature in individuals affected with Factor VIII Deficiency (Hemophilia A) without strong evidence of causality (e.g. Higuchi_1991b, Chan_1996, Hwang_2009, Luu_2019, Li_2020, Chen_2021). These reports do not provide unequivocal conclusions about association of the variant with Factor VIII Deficiency (Hemophilia A). At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in reduced FVIII activity and antigen values in HEK293T cells (Pahl_2014). The following publications have been ascertained in the context of this evaluation (PMID: 1924291, 8639447, 19719548, 29296726, 32190902, 34272389, 33706050, 33245802, 35770352, 30913330, 24108539). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified it as uncertain significance (n=2), likely pathogenic (n=1) or pathogenic (n=1). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Uncertain
0.029
T
BayesDel_noAF
Pathogenic
0.27
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.42
T
FATHMM_MKL
Benign
0.036
N
LIST_S2
Benign
0.63
T
M_CAP
Pathogenic
0.97
D
MetaRNN
Benign
0.17
T
MetaSVM
Uncertain
0.72
D
MutationAssessor
Benign
1.6
L
MutationTaster
Benign
9.6e-10
A
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.99
N
REVEL
Pathogenic
0.65
Sift
Uncertain
0.010
D
Sift4G
Uncertain
0.035
D
Polyphen
0.68
P
Vest4
0.65
MVP
0.99
MPC
0.15
ClinPred
0.035
T
GERP RS
2.9
Varity_R
0.16
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28933673; hg19: chrX-154158896; COSMIC: COSV64277732; API